A Novel, Non-Cytotoxic, Epigenetic Therapeutic for Sickle Cell Disease

$750,000R44FY2019HLNIH

Denovotherapies, Llc, Akron OH

Investigators

Joseph Desimonecontact Yogen Saunthararajah

Linked publications, trials & patents

Paper 37597186 Paper 37417197 Paper 35603902 Paper 34551907 Paper 34551289 Paper 29958562 Trial NCT04055818

View original record on NIH RePORTER →